Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Surgical News

12/6/2024
BreakingEuropeIOLPresbyopiaRefractiveSurgical
Ophtec Receives CE Marking for Artiplus Phakic IOL, Targets Young Presbyopes
Ophtec Receives CE Marking for Artiplus Phakic IOL, Targets Young Presbyopes

Dutch company Ophtec announced Nov. 18 that it had gained CE Mark approval for its Artiplus phakic intraocular lens (IOL). The company said the lens offered a solution for relatively young presbyop...

11/27/2024
BreakingGlaucomaLaserMIGSRegulationSurgical
MACs Finalize Coverage for Standalone and Combo MIGS Procedures
MACs Finalize Coverage for Standalone and Combo MIGS Procedures

Five Medicare administrative contractors have issued their final coverage policies for minimally invasive glaucoma surgery, or MIGS, along with more technical billing and coding documents. The poli...

11/22/2024
BreakingCataractGlaucomaLaserRegulationRetinaSurgical
CMS Cuts Ophthalmologists’ Procedure Fees, While Raising ASC, HOPD Facility Fees
CMS Cuts Ophthalmologists’ Procedure Fees, While Raising ASC, HOPD Facility Fees

The Centers for Medicare and Medicaid Services (CMS) published on Nov. 1 the final schedule of Medicare reimbursement fees for physicians in 2025. It also released its facility fee payments for ASC...

11/15/2024
BreakingCataractChinaDry EyeGlaucomaIOLLaserRevenueSurgical
Q3-2024 Ophthalmic Revenue Roundup for Alcon, Hoya, RxSight, Sight Sciences, and Iridex
Q3-2024 Ophthalmic Revenue Roundup for Alcon, Hoya, RxSight, Sight Sciences, and Iridex

Alcon reported Nov. 12 that its Q3-2024 net sales totaled $2.4 billion, a 6 percent increase over $2.3 billion in Q3-2023. Surgical net sales for implantables, consumables, and equipment/other were...

11/14/2024
AAOCataractMeetingNewsletterSurgical
Zeiss Bolsters Launch of Micor 700 at AAO Meeting With US Surgeons Discussing Adoption
Zeiss Bolsters Launch of Micor 700 at AAO Meeting With US Surgeons Discussing Adoption

Carl Zeiss Meditec featured its Micor 700 at the 2024 meeting of the American Academy of Ophthalmology in Chicago, Illinois, with presentations that included booth talks by select US surgeons who h...

11/14/2024
AIDealsDiagnosticFundingGene TherapyGlaucomaNewsletterRetinaSurgical
EyePoint Leads Latest Ophthalmic Fundraising with $161 Million Public Offering
EyePoint Leads Latest Ophthalmic Fundraising with $161 Million Public Offering

EyePoint Pharmaceuticals led recent ophthalmic fundraising efforts with a $161 million upsized underwritten public offering. Proceeds in part will fund clinical development of Duravyu. Financing an...

11/14/2024
AAOCataractMeetingNewsletterSurgical
Office-Based Surgery Garners Enthusiasm at 2024 AAO Meeting
Office-Based Surgery Garners Enthusiasm at 2024 AAO Meeting

Several sessions at the 2024 American Academy of Ophthalmology meeting highlighted the trend of office-based surgery (OBS) and the option of oral sedation among practitioners. The consensus among t...

11/14/2024
AAOCataractIOLMeetingNewsletterPremiumSurgical
New Trifocal IOLs Expected to Help the US Resume PC-IOL Growth
New Trifocal IOLs Expected to Help the US Resume PC-IOL Growth

Bausch + Lomb’s enVista Envy and J&J Vision’s Odyssey are two new trifocal IOLs that were shown at the 2024 AAO meeting in Chicago. They are expected to help reverse the decline in trifocal IOL sal...

11/14/2024
AAODeviceEyeceleratorGlaucomaMeetingNewsletterSurgical
AAO and Eyecelerator Sessions Showcase Latest in Glaucoma Lasers and Surgical Devices
AAO and Eyecelerator Sessions Showcase  Latest in Glaucoma Lasers and Surgical Devices

New glaucoma lasers and surgical devices were shown at various venues during the 2024 AAO meeting, including Glaucoma Subspecialty Day and the Eyecelerator meeting. There was also an important upda...

11/14/2024
AAOMeetingNewsletterRetinaSurgical
Alcon Looks to Refine Retinal Surgery with Unifeye, Unipexy
Alcon Looks to Refine Retinal Surgery with Unifeye, Unipexy

Alcon launched at the 2024 AAO meeting two new retinal surgical devices—Unifeye for air-gas exchange and Unipexy for retinopexy. Each is a one-person, hand-held, single-use gas delivery device. The...

11/14/2024
AAODiagnosticNewsletterSurgical
AAO and Eyenuk Collaborate on AI-Driven DR Screening for Underserved Patients
AAO and Eyenuk  Collaborate on AI-Driven  DR Screening for  Underserved Patients

Eyenuk and the American Academy of Ophthalmology (AAO) reported Oct. 16 that they had teamed up under the AAO’s EyeCare America program to provide eye disease screening for underserved communities ...

11/14/2024
CataractNewsletterPremiumSurgical
Private Practices Key to US Premium Cataract Surgery Market Dominance
Private Practices Key to US Premium Cataract Surgery Market Dominance

The US represents only 5 percent of the global population in 2024, but it accounts for nearly 36 percent of the world’s premium cataract surgery (PCS) market revenue. The US has the latest premium ...

11/14/2024
DiagnosticMicroscopesNewsletterSurgical
Haag-Streit’s Metis Poised to Join Innovation-Rich and Growing Advanced Microscopes Segment
Haag-Streit’s Metis Poised to Join Innovation-Rich and Growing Advanced Microscopes Segment

Haag-Streit revealed its new Metis microscope at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting and showcased it again at the 2024 AAO meeting. The Metis is specifica...

11/14/2024
AllergyCataractClinical TrialCornealGlaucomaNewsletterPresbyopiaRetinaSurgical
Clinical Trial Updates for Ophthalmic Candidates, November 2024
Clinical Trial Updates for Ophthalmic Candidates, November 2024

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

11/14/2024
CataractClinical TrialDealsDiagnosticDry EyeFundingGene TherapyGlaucomaIndustryInstrumentsMicroscopesNewsletterOCTPresbyopiaRegulationRetinaStudySurgical
November 2024 Ophthalmic News Briefs
November 2024 Ophthalmic News Briefs

Heidelberg Engineering announced Oct. 14 that the US FDA had granted 510(k) clearance to its Flex Module for the Spectralis diagnostic imaging platform. The Flex Module mounts the Spectralis to a m...

11/14/2024
NewsletterOptometrySurgical
Weekly Poll of Surgeons and Eye Doctors, November 2024
Weekly Poll of Surgeons and Eye Doctors, November 2024

11/8/2024
BreakingCataractCornealDry EyeGlaucomaLaserPharmaPresbyopiaRefractiveRetinaRevenueSurgical
Q3-2024 Ophthalmic Revenue Roundup for AbbVie, Apellis, Glaukos, STAAR, and Lensar
Q3-2024 Ophthalmic Revenue Roundup for AbbVie, Apellis, Glaukos, STAAR, and Lensar

AbbVie, of North Chicago, Illinois, reported Oct. 30 that its Q3-2024 eye care net revenue was $525 million, a 13.5 percent decline (-11.2 percent cc) from $605 million in Q3-2023. Restasis revenue...

10/25/2024
BreakingIOLPharmaRetinaRevenueSurgical
Q3-2024 Ophthalmic Revenue Roundup for Roche and J&J Vision
Q3-2024 Ophthalmic Revenue Roundup for Roche and J&J Vision

Swiss company Roche reported Oct. 23 that Q3-2024 Vabysmo sales were CHF 1 billion ($1.15 billion, converted on Oct. 23, 2024), a 59 percent increase over CHF 656 million in Q3-2023. The company sa...

10/25/2024
BreakingInstrumentsSingle-UseSurgical
Corza Launches Onatec Ophthalmic Microsurgical Suture Portfolio
Corza Launches Onatec Ophthalmic Microsurgical Suture Portfolio

Corza Medical, of Westwood, Massachusetts, reported Oct. 21 that it had launched its Onatec ophthalmic microsurgical suture portfolio of needles and suture material. The company said Onatec needles...

10/18/2024
BreakingCataractIOLRegulationSurgical
Bausch + Lomb Gains US FDA Approval of enVista Envy Trifocal IOL
Bausch + Lomb Gains US FDA Approval of enVista Envy Trifocal IOL

Bausch + Lomb reported Oct. 14 that the US FDA had approved itsenVista Envy trifocal intraocular lens. The lens is available on a limited basis in the US and will be launched more broadly in 2025. ...

10/18/2024
AAOAIBreakingDiagnosticRetinaSurgical
Eyenuk, AAO Collaborate to Offer AI-Driven DR Screening for Underserved Patients in Delaware
Eyenuk, AAO Collaborate to Offer AI-Driven DR Screening for Underserved Patients in Delaware

Eyenuk and the American Academy of Ophthalmology (AAO) reported Oct. 16 that they had teamed up under the AAO’s EyeCare America program to provide eye disease screening for underserved communities ...

10/18/2024
BreakingCataractCornealSurgical
Cure Blindness Project Expands Sight-Saving Care to Six New Countries
Cure Blindness Project Expands Sight-Saving Care to Six New Countries

Cure Blindness Project is expanding to six new countries—Burundi, Democratic Republic of the Congo, Liberia, Pakistan, Paraguay, and Zambia, the charity reported Oct. 10. Paraguay marksthe charity’...

10/18/2024
BreakingCataractFLACSSurgical
Lensar Marks 1 Million Procedures Using its Femtosecond Cataract Lasers
Lensar Marks 1 Million Procedures Using its Femtosecond Cataract Lasers

Lensar reported Oct. 8 that surgeons had performed more than 1 million procedures using its Lensar femtosecond cataract systems. The Orlando, Florida, company introduced its original Lensar Laser S...

10/15/2024
EuropeMeetingNewsletterRetinaSurgical
Retina Surgeons at European Meetings Ask, ‘What’s New?’
Retina Surgeons  at European Meetings Ask, ‘What’s New?’

Experienced retina surgeons among the approximately 8.1 thousand attendees at Euretina in Barcelona, Spain, were underwhelmed by the surgical devices that industry had on display. “There is nothing...

10/15/2024
ESCRSEuropeHyperopiaMeetingNewsletterRefractiveSurgical
Hyperopia Treatment Using Lenticule Extraction Showcased to Eager European Ophthalmologists
Hyperopia Treatment Using Lenticule Extraction Showcased to Eager European Ophthalmologists

Dan Reinstein, MD (UK), shared during an overly full symposium at the 2024 ESCRS congress his experience using Zeiss’ SMILE lenticule extraction procedure to treat hyperopic patients. Zeiss is the ...

10/15/2024
ESCRSEuropeMeetingNewsletterRefractiveSurgical
Bausch + Lomb Launches Octavius Topo-Guided Treatment at ESCRS Congress
Bausch + Lomb Launches Octavius Topo-Guided Treatment at ESCRS Congress

Bausch + Lomb showcased its CE marked Octavius at the 2024 ESCRS Congress. Octavius is a new treatment mode on the Teneo excimer laser that uses data from multiple diagnostic platforms to provide a...

10/15/2024
Clinical TrialCornealDry EyeGene TherapyGlaucomaIOLNewsletterOcular CancerRetinaSurgical
Clinical Trial Updates for Ophthalmic Candidates, October 2024
Clinical Trial Updates for Ophthalmic Candidates, October 2024

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

10/15/2024
IndustryInstrumentsNewsletterSurgical
Zeiss Invests $24 Million to Expand Production Site in Chesterfield, Missouri
Zeiss Invests $24 Million to Expand Production Site in Chesterfield, Missouri

German company Carl Zeiss Meditec opened a new state-of-the-art research and production facility on Oct. 1 in Chesterfield, Missouri, expanding its footprint in the city, which is part of the St. L...

10/15/2024
NewsletterRefractiveRegulationSurgical
FTC Sends More Than $1.1 Million to Consumers Misled by LCA-Vision Ads
FTC Sends More Than $1.1 Million to Consumers Misled by LCA-Vision Ads

The Federal Trade Commission (FTC) announced Oct. 3 that it was sending more than $1.1 million in settlement payments to consumers who were misled by deceptive bait-and-switch advertising by LCA-Vi...

10/15/2024
ChinaClinical TrialDealsDiagnosticDry EyeEuropeGene TherapyGlaucomaIndiaIndustryLaserNewsletterPerimetryRegulationRetinaSurgical
October 2024 Ophthalmic News Briefs
October 2024 Ophthalmic News Briefs

Oculus has announced the addition of frequency doubling perimetry (FDP) to its Easyfield VR visual field diagnostic headset. The German ophthalmic diagnostic company, with US headquarters in Arling...

10/15/2024
NewsletterRefractiveSurgical
Weekly Surgeon Poll, October 2024
Weekly Surgeon Poll, October 2024

10/11/2024
BreakingRefractiveRegulationSurgical
FTC Sends More Than $1.1 Million to Consumers Misled by LCA-Vision Ads
FTC Sends More Than $1.1 Million to Consumers Misled by LCA-Vision Ads

The Federal Trade Commission (FTC) announced Oct. 3 that it was sending more than $1.1 million in settlement payments to consumers who were misled by deceptive bait-and-switch advertising by LCA-Vi...

10/4/2024
BreakingRetinaSurgical
Harrow Relaunches Triesence Ophthalmic Corticosteroid in US
Harrow Relaunches Triesence Ophthalmic Corticosteroid in US

Nashville, Tennessee-based Harrow reported Oct. 3 that it had relaunchedTriesence (triamcinolone acetonide injectable suspension) 40 mg/mL, a preservative‑free synthetic corticosteroid, in the US. ...

10/4/2024
BreakingIndustryInstrumentsSurgical
Zeiss Invests $24 Million to Expand Production Site in Chesterfield, Missouri
Zeiss Invests $24 Million to Expand Production Site in Chesterfield, Missouri

German company Carl Zeiss Meditec opened a new state-of-the-art research and production facility on Oct. 1 in Chesterfield, Missouri, expanding its footprint in the city, which is part of the St. L...

9/27/2024
BreakingCataractSurgical
Zeiss Announces Broad US Rollout of Micor 700 for Phaco-less Cataract Surgery
Zeiss Announces Broad US Rollout of Micor 700 for Phaco-less Cataract Surgery

Carl Zeiss Meditec reported Sept. 26 that it had begun broad US distribution of the Micor 700, the first hand-held device to extract a crystalline lens in cataract surgery without the need for ultr...

9/27/2024
BreakingDealsInstrumentsRetinaSurgical
Microsurgical Technology (MST) to Commercialize Vista Vitrectomy Products
Microsurgical Technology (MST) to Commercialize Vista Vitrectomy Products

Microsurgical Technology (MST) announced Sept. 17 that it had partnered with Vista Ophthalmics to commercialize Vista’s products—the Vista 1-Step vitrectomy probe and the Vista IS for maintaining t...

9/20/2024
BreakingStudySurgical
NYU Langone Hails Recovery of Man Over a Year after Landmark Whole Eye Transplant
NYU Langone Hails Recovery of Man Over a Year after Landmark Whole Eye Transplant

A surgical team at NYU Langone Health performed the world’s first whole eye and partial-face transplant in May 2023 for Aaron James, who had survived a high-voltage electrical accident at work. Ove...

9/19/2024
NewsletterRetinaStudySurgical
OcuDyne Reports Positive Pilot Study Results Using Ophthalmic Artery Angioplasty in GA
OcuDyne Reports Positive Pilot Study Results Using Ophthalmic Artery Angioplasty in GA

OcuDyne, of Brooklyn Park, Minnesota, reported Sept. 9 that it had successfully completed a pilot study using its Optic System to perform ophthalmic artery angioplasty in patients with geographic a...

9/19/2024
Dry EyeEmergingGene TherapyNewsletterRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, September 2024
Emerging Companies Pursuing Ophthalmic Indications, September 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

9/19/2024
CataractNewsletterRegulationSurgical
Precision Lens and Estate of Paul Ehlen to Pay US $12M over Kickbacks
Precision Lens and Estate of Paul Ehlen to Pay US $12M over Kickbacks

Minnesota-based ophthalmic distributor Precision Lens and the estate of co-founder Paul Ehlen have agreed to pay the US government $12 million to resolve a case involving kickback payments in vario...

9/19/2024
AmblyopiaClinical TrialDiagnosticFundusGene TherapyGlaucomaIndustryNewsletterRegulationRetinaSurgical
September 2024 Ophthalmic News Briefs
September 2024 Ophthalmic News Briefs

Bausch + Lomb is working with Goldman Sachs to explore a sale of the company, the Financial Times reported Sept. 14, with private equity the most likely buyer. The move is being evaluated as a way ...

9/19/2024
CataractIOLNewsletterPremiumSurgical
Weekly Surgeon Poll, September 2024
Weekly Surgeon Poll, September 2024

9/13/2024
BreakingClinical TrialRetinaStudySurgical
OcuDyne Reports Positive Pilot Study Results Using Ophthalmic Artery Angioplasty in GA
OcuDyne Reports Positive Pilot Study Results Using Ophthalmic Artery Angioplasty in GA

OcuDyne, of Brooklyn Park, Minnesota, reported Sept. 9 that it had successfully completed a pilot study using its Optic System to perform ophthalmic artery angioplasty in patients with geographic a...

9/13/2024
BreakingGlaucomaIndustryMIGSSurgical
iStar Medical Appoints Richard Beckman, MD, as Chief Medical Officer
iStar Medical Appoints Richard Beckman, MD, as Chief Medical Officer

Belgium’s iStar Medical announced Sept. 4 that it had appointed Richard Beckman, MD, as chief medical officer and member of the company’s board. Beckman most recently served as CMO of Adverum Biote...

9/6/2024
BreakingEuropeRefractiveSurgical
Carl Zeiss Meditec Introduces Hyperopia Treatment Using Lenticule Extraction
Carl Zeiss Meditec Introduces Hyperopia Treatment Using Lenticule Extraction

German company Carl Zeiss Meditec reported Aug. 24 that it had become the first medical device manufacturer to introduce in the CE market the treatment of hyperopia using lenticule extraction. This...

8/30/2024
BreakingCataractESCRSEuropeIOLSurgical
Rayner to Roll Out First Spiral IOL at 2024 ESCRS Congress
Rayner to Roll Out First Spiral IOL at 2024 ESCRS Congress

UK-based Rayner reported Aug. 26 that it was set to launch the first spiral intraocular lens models—the RayOne Galaxy and Galaxy Toric—at the 2024 ESCRS Congress, set for Sept. 6-10 in Barcelona, S...

8/30/2024
BreakingCataractIOLRevenueSingle-UseSurgical
Alcon Reports Q2-2024 Net Sales of $2.5 Billion
Alcon Reports Q2-2024 Net Sales of $2.5 Billion

Alcon reported Aug. 20 that its Q2-2024 net sales totaled $2.5 billion, a record quarter for the company and a 3 percent increase (+6 percent cc) over $2.4 billion in Q2-2023. Surgical net sales fo...

8/30/2024
BreakingCataractRegulationSurgical
Precision Lens and Estate of Paul Ehlen to Pay US $12M over Kickbacks
Precision Lens and Estate of Paul Ehlen to Pay US $12M over Kickbacks

Minnesota-based ophthalmic distributor Precision Lens and the estate of co-founder Paul Ehlen have agreed to pay the US government $12 million to resolve a case involving kickback payments in vario...

8/21/2024
CataractEnvironmentGlaucomaNewsletterSingle-UseSurgical
Steady Growth Expected in Single-Use Surgical Products, Even With Push to Cut OR Waste
Steady Growth Expected in Single-Use Surgical Products, Even With Push to Cut OR Waste

Environmental sustainability programs have grown in scope over the last five years, with major ophthalmic surgery associations joining forces to propose specific actions to reduce the carbon footpr...

8/21/2024
EuropeGlaucomaLaserNewsletterRegulationSurgical
ViaLase Gains CE Marking for Femtosecond Laser for Glaucoma Treatment
ViaLase Gains CE Marking for Femtosecond Laser for Glaucoma Treatment

ViaLase announced July 30 that the European Union had granted CE marking for its ViaLase Laser for the treatment of adults with primary open-angle glaucoma. The system uses an OCT-guided femtosecon...

8/21/2024
NewsletterRefractiveStudySurgical
OHSU Researchers Discover Link Between Proteins in Tears, Pain After Eye Surgery
OHSU Researchers Discover Link Between Proteins in Tears, Pain  After Eye Surgery

Researchers at Oregon Health & Science University (OHSU) say they have discovered a connection between postsurgical ocular pain and levels of certain proteins found in patients’ tears. Some patient...

8/21/2024
CataractEuropeMeetingNewsletterRefractiveSurgical
Meet with Market Scope at the 2024 ESCRS Congress
Meet with Market Scope at the 2024 ESCRS Congress

Market Scope will be exhibiting at the 2024 ESCRS congress, which is Sept. 6-10 in Barcelona, Spain. We will be located at Stand 6.D12. Contact us to set up a time to discuss any custom research ne...

8/21/2024
CataractCornealNewsletterSurgical
Renowned Charity HCP Cureblindness Rebrands as Cure Blindness Project
Renowned Charity HCP Cureblindness Rebrands as Cure Blindness Project

HCP Cureblindness has rebranded as the Cure Blindness Project, the group announced July 29. The move is designed to better reflect the eye charity’s expanded geographical footprint and commitment t...

8/16/2024
BiosimilarsBreakingCataractDiagnosticDry EyeGlaucomaLaserOcular CancerRefractiveRetinaRevenueSurgical
Q2-2024 Ophthalmic Revenue Roundup for AbbVie, Carl Zeiss Meditec, Amgen, STAAR, Astellas, Immunocore, Tarsus, Biogen, Lensar, and Iridex
Q2-2024 Ophthalmic Revenue Roundup for AbbVie, Carl Zeiss Meditec,  Amgen, STAAR, Astellas, Immunocore, Tarsus, Biogen, Lensar, and Iridex

AbbVie, of North Chicago, Illinois, reported July 25 that Q2-2024 net revenue for its eye care products totaled $533 million, a 13.3 percent decline (-10.9 percent cc) from $617 million in Q2-2023....

8/8/2024
BreakingCataractDealsSurgical
Lensar Ends Collaboration with Oertli for Phaco Portion of Ally Cataract System
Lensar Ends Collaboration with Oertli for Phaco Portion of Ally Cataract System

Lensar has terminated its collaboration agreement with Swiss company Oertli, according to a filing Aug. 5 with the US Securities and Exchange Commission. The two had been developing the Ally Adapti...

8/9/2024
BreakingCataractDry EyeGlaucomaIOLRetinaRevenueSurgical
Q2-2024 Ophthalmic Revenue Roundup for Hoya, Harrow, RxSight, Sight Sciences, Ocular Therapeutix, and EyePoint
Q2-2024 Ophthalmic Revenue Roundup for Hoya, Harrow, RxSight, Sight Sciences, Ocular Therapeutix, and EyePoint

Japan-based Hoya Corporation announced Aug. 1 that its medical care segment (IOLs, endoscopes, artificial bone) had revenue for the quarter ending June 30, 2024—the first quarter of its fiscal year...

8/9/2024
BreakingCataractDealsDry EyePharmaSurgical
Formosa Licenses Clobetasol Propionate Drops to Apotex for Canada
Formosa Licenses Clobetasol Propionate Drops to Apotex for Canada

Taiwan-based Formosa Pharmaceuticals announced Aug. 5 that it had agreed to license to Apotex exclusive rights to market clobetasol propionate 0.05% eye drops for postsurgical inflammation and pain...

8/9/2024
BreakingCataractCornealSurgical
HCP Cureblindness Rebrands as Cure Blindness Project
HCP Cureblindness Rebrands as Cure Blindness Project

HCP Cureblindness has rebranded as the Cure Blindness Project, the group announced July 29. The move is designed to better reflect the eye charity’s expanded geographical footprint and commitment t...

8/2/2024
BreakingEuropeGlaucomaLaserRegulationSurgical
ViaLase Gains CE Marking for Femtosecond Laser for Glaucoma Treatment
ViaLase Gains CE Marking for Femtosecond Laser for Glaucoma Treatment

ViaLase announced July 30 that the European Union had granted CE marking for its ViaLase Laser for the treatment of adults with primary open-angle glaucoma. The system uses an OCT-guided femtosecon...

8/2/2024
BreakingCornealDiagnosticDry EyeGlaucomaIOLLaserRetinaRevenueSurgical
Q2-2024 Ophthalmic Revenue Roundup for Regeneron, Roche, Bausch + Lomb, Novartis, and Four Others
Q2-2024 Ophthalmic Revenue Roundup for Regeneron, Roche, Bausch + Lomb, Novartis, and Four Others

Regeneron, of Tarrytown, New York, reported Aug. 1 that its Q2-2024 US revenue for Eylea was $1.53 billion, a 2 percent increase from $1.5 billion in Q2-2023. Eylea HD accounted for $304 million of...

8/2/2024
BreakingRefractiveStudySurgical
OHSU Researchers Discover Link Between Proteins in Tears, Pain After Eye Surgery
OHSU Researchers Discover Link Between Proteins in Tears, Pain After Eye Surgery

Researchers at Oregon Health & Science University (OHSU) say they have discovered a connection between postsurgical ocular pain and levels of certain proteins found in patients’ tears. Some patient...

7/26/2024
BreakingCornealDealsDiagnosticDry EyeSurgical
Bausch + Lomb Acquires Dry Eye Diagnostic Company Trukera Medical
Bausch + Lomb Acquires Dry Eye Diagnostic Company Trukera Medical

Bausch + Lomb announced July 23 that it had acquired dry eye diagnostic company Trukera Medical from its private equity owner, AccelMed Partners, and other shareholders. No financial details were d...

7/26/2024
BreakingChinaLow VisionRetinaSurgical
Samsara Says First SING IMT for AMD Has Been Implanted in China
Samsara Says First SING IMT for AMD Has Been Implanted in China

Samsara Vision, of Far Hills, New Jersey, announced July 22 that the first SING IMT procedure for age-related macular degeneration (AMD) had been completed in China. The SING IMT, which stands for ...

7/26/2024
BreakingGlaucomaIndustrySurgical
Cancer Company TME Pharma Plans to Spin Off NOX-E36 for Eye Disease
Cancer Company TME Pharma Plans to Spin Off NOX-E36 for Eye Disease

Germany’s TME Pharma, a clinical-stage cancer company, announced July 22 that it planned to spin off its asset NOX-E36 to advance it for eye disease. NOX-E36 is an L-stereoisomer RNA aptamer inhibi...

7/23/2024
DeviceGlaucomaNewsletterSurgical
Multitude of Novel Glaucoma Surgery Devices to Drive Procedure Growth
Multitude of Novel Glaucoma Surgery Devices to Drive Procedure Growth

The goal of a growing number of companies entering the already crowded glaucoma device market is to provide surgical treatment options with greater safety and effectiveness. Thirty-six products are...

7/23/2024
NewsletterRefractiveSurgical
Ophthalmic Chain in Colorado Closing All Six Clinics, Citing COVID-19 Financial Fallout
Ophthalmic Chain in Colorado Closing All Six Clinics, Citing COVID-19 Financial Fallout

Rocky Mountain Eye Center, based in Pueblo, Colorado, announced on its website that it will close all of its six clinics on July 31, saying the practice was unable to recover from the financial fal...

7/23/2024
CataractNewsletterRetinaSurgical
Weekly Surgeon Poll, July 2024
Weekly Surgeon Poll, July 2024

7/19/2024
BreakingCataractIOLRevenueSurgical
J&J Vision Generates Q2-2024 Surgical Revenue of $367 Million
J&J Vision Generates Q2-2024 Surgical Revenue of $367 Million

J&J Vision’s Q2-2024 global surgical revenue totaled $367 million, a 0.5 percent decrease (1.2 percent increase in constant currency) from $369 million in Q2-2023, parent Johnson & Johnson, of New ...

7/19/2024
BreakingRefractiveSurgical
Ophthalmic Chain in Colorado Closing All Six Clinics, Citing COVID-19 Financial Fallout
Ophthalmic Chain in Colorado Closing All Six Clinics, Citing COVID-19 Financial Fallout

Rocky Mountain Eye Center, based in Pueblo, Colorado, announced on its website that it will close all of its six clinics on July 31, saying the practice was unable to recover from the financial fal...

7/11/2024
BreakingCataractDealsEuropeRefractiveSurgical
Ophthalmology Chain Clínica Baviera Enters UK Market with Acquisition of Optimax
Ophthalmology Chain Clínica Baviera Enters UK Market with Acquisition of Optimax

European ophthalmology chain Clínica Baviera has extended its reach into the UK with the purchase of Optimax. Optimax (Eye Hospitals Group and subsidiaries) operates 19 clinics under the Optimax an...

6/28/2024
BreakingCataractRegulationRetinaSurgical
Alcon Gains US FDA 510(k) Clearance for Unity VCS and CS Systems
Alcon Gains US FDA 510(k) Clearance for Unity VCS and CS Systems

Alcon reported June 24 that itsUnity Vitreoretinal Cataract System (VCS) and Unity Cataract System (CS) had received US FDA 510(k) clearance. The company said it would be seeking real-world feedbac...

6/28/2024
BreakingPharmaRegulationRetinaSurgical
Harrow Looks to Relaunch Triesence in 2024, as Production Testing Continues
Harrow Looks to Relaunch Triesence in 2024, as Production Testing Continues

Nashville, Tennessee-based Harrow reported June 20 that it was moving closer to relaunching Triesence in 2024 after successfully achieving a production testing milestone. Triesence (triamcinolone a...

6/24/2024
DiagnosticFundusGlaucomaIOLNewsletterOCTRegulationSurgical
Select US FDA Approvals and Clearances in May 2024
Select US FDA Approvals and Clearances in May 2024

The US FDA granted six clearances through the ophthalmic device division using the 510(k) pathway in May 2024, according to the agency’s database. Reichert gained market clearance for its new hand-...

6/24/2024
CataractClinical TrialDry EyeNewsletterRetinaSurgical
Clinical Trial Updates for Ophthalmic Candidates, June 2024
Clinical Trial Updates for Ophthalmic Candidates, June 2024

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

6/24/2024
CataractGlaucomaNewsletterRegulationSurgical
Surgeons, Societies Respond to MACs’ New Proposed MIGS Limits
Surgeons, Societies Respond to MACs’ New Proposed MIGS Limits

Surgeons and ophthalmic societies worked together at open meetings in June to address five Medicare administrative contractors’ latest proposal to limit coverage of minimally invasive glaucoma surg...

6/24/2024
DiagnosticEmergingMicroscopesNewsletterPharmaSurgicalTelehealth
Emerging Companies Pursuing Ophthalmic Indications, June 2024
Emerging Companies Pursuing Ophthalmic Indications, June 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

6/24/2024
CataractClinical TrialData SecurityDealsDiagnosticDry EyeGene TherapyGlaucomaIOLIndustryMyopiaNewsletterRefractiveRegulationRetinaSurgical
June 2024 Ophthalmic News Briefs
June 2024 Ophthalmic News Briefs

Japan’s Nidek announced June 3 that it had launched the RS-1 Glauvas OCT system. The device is CE marked as a Class IIa device. Nidek said the RS-1 Glauvas’ streamlined workflow and advanced analyt...

6/14/2024
BreakingCataractRegulationSurgical
WPS MAC Revisits Changing Coverage for Cataract Surgery
WPS MAC Revisits Changing Coverage for Cataract Surgery

WPS Insurance Corporation, a Medicare administrative contractor (MAC) in the US, has again proposed changing its coverage of cataract surgery after putting forth a similar proposal in September 202...

6/14/2024
BreakingCataractEuropeIOLRegulationSurgical
Nidek Gains CE Marking for Preloaded IOL Injector System
Nidek Gains CE Marking for Preloaded IOL Injector System

Japan’s Nidek announced June 10 that it had received CE marking for the NP-1/NP-1C preloaded IOL injection system. The system is preloaded with the Aktis aspheric hydrophobic soft acrylic lens, whi...

6/7/2024
BreakingGlaucomaRegulationSurgical
MACs Propose New Limits on MIGS Procedures
MACs Propose New Limits on MIGS Procedures

Five Medicare administrative contractors have proposed new limits to their coverage of minimally invasive glaucoma surgery (MIGS). The move comes a year after the same MACs roiled the glaucoma subs...

6/7/2024
DealsRefractiveSurgical
Sightpath Medical Acquires LASIK Services Business PennVista
Sightpath Medical Acquires LASIK Services Business PennVista

Sightpath Medical announced May 30 that it had acquired PennVista, a LASIK services business operating in Pennsylvania, Ohio, West Virginia, Indiana, and Michigan. Financial details were not disclo...

5/31/2024
BreakingCataractIOLOcular CancerRevenueSurgical
Q1-2024 Ophthalmic Revenue Roundup for Amgen, Hoya, and Immunocore
Q1-2024 Ophthalmic Revenue Roundup for Amgen, Hoya, and Immunocore

Amgen, of Thousand Oaks, California, reported May 2 that its Q1-2024 revenue from Tepezza was $424 million. The total consisted of $419 million in the US and $5 million outside the US. The company ...

5/31/2024
BreakingCataractIOLRegulationSurgical
Bausch + Lomb Receives Health Canada Approval for EnVista Envy Trifocal IOL
Bausch + Lomb Receives Health Canada Approval for EnVista Envy Trifocal IOL

Bausch + Lomb announced May 28 that Health Canada had approved the enVista Envy trifocal intraocular lens (IOL). It’s the first approval for the new lens. The Envy is expected to be available in Ca...

5/24/2024
BreakingGlaucomaRegulationSurgical
New World Medical Gains US 510(k) Clearance for KDB Glide
New World Medical Gains US 510(k) Clearance for KDB Glide

New World Medical reported May 22 that its Kahook Dual Blade Glide (KDB Glide) had gained US FDA 510(k) clearance. The KDB Glide was previously classified as a Class 1, 510(k)-exempt device. With t...

5/22/2024
CataractMeetingNewsletterRetinaSurgical
Champalimaud Vision Award Recognizes Eye Hospital Serving Gaza and West Bank
Champalimaud Vision Award Recognizes  Eye Hospital Serving Gaza and West Bank

A sparsely attended Champalimaud Vision Award Lecture at the 2024 ARVO meeting highlighted the work of St. John of Jerusalem Eye Hospital in Gaza, Jerusalem, and the West Bank. Leonor Beleza, presi...

5/22/2024
CornealDiagnosticDry EyeEmergingGene TherapyGlaucomaNewsletterOcular CancerRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, May 2024
Emerging Companies Pursuing Ophthalmic Indications, May 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

5/22/2024
GlaucomaNewsletterPatentSurgical
Sight Sciences Announces $34 Million Jury Verdict in Patent Infringement Case
Sight Sciences Announces $34 Million Jury Verdict in Patent Infringement Case

Sight Sciences, of Menlo Park, California, reported April 29 that it had received a $34 million jury trial verdict in its patent infringement case against Ivantis and acquirer Alcon. The suit, file...

5/17/2024
BreakingDiagnosticDry EyePharmaRetinaRevenueSurgical
Q1-2024 Ophthalmic Revenue Roundup for Alcon, Carl Zeiss Meditec, and Harrow
Q1-2024 Ophthalmic Revenue Roundup for Alcon, Carl Zeiss Meditec, and Harrow

Alcon reported May 13 that its Q1-2024 net sales were $2.4 billion, a 5 percent increase (+7 percent cc) over $2.3 billion in Q1-2023. Surgical net sales totaled $1.34 billion, consisting of $433 m...

5/17/2024
BreakingRetinaSurgical
First-in-Human Robotic Bimanual Vitrectomy Performed in Belgium
First-in-Human Robotic Bimanual Vitrectomy Performed in Belgium

Healio reported May 14 that the first-in-human bimanual vitrectomy performed with a robot had taken place at Belgium’s Ghent University Hospital. The case was presented at the Retina World Congress...

5/17/2024
BreakingMicroscopesSurgical
First Beyeonics One Ophthalmic Exoscope Installed at ASC in Florida
First Beyeonics One Ophthalmic Exoscope Installed at ASC in Florida

Israel’s Beyeonics Vision reported May 10 the first commercial installation of a Beyeonics One digital ophthalmic exoscope at Largo Ambulatory Surgery Center & Eye Institute in Largo, Florida. The ...

5/10/2024
BreakingCataractDry EyeGlaucomaRefractiveRetinaRevenueSurgical
Q1-2024 Ophthalmic Revenue Roundup for Apellis, STAAR, RxSight, Tarsus, Sight Sciences, and Three Others
Q1-2024 Ophthalmic Revenue Roundup for Apellis, STAAR, RxSight, Tarsus, Sight Sciences, and Three Others

Apellis Pharmaceuticals, of Waltham, Massachusetts, reported May 7 that its Q1-2024 US net product revenue for Syfovre was $137.5 million, compared with $18.4 million in Q1-2023. Syfovre gained US ...

5/3/2024
BreakingCataractDry EyeGlaucomaLaserRevenueSurgical
Q1-2024 Ophthalmic Revenue Roundup for Bausch + Lomb, Glaukos, and Lumibird
Q1-2024 Ophthalmic Revenue Roundup for Bausch + Lomb, Glaukos, and Lumibird

Bausch + Lomb reported May 1 that its Q1-2024 revenue was $1.1 billion, an 18 percent increase (+20 percent cc) over $931 million in Q1-2023. Vision Care segment revenue in Q1-2024 was $635 million...

5/3/2024
BreakingGlaucomaPatentSurgical
Sight Sciences Announces $34 Million Jury Verdict in Patent Infringement Case
Sight Sciences Announces $34 Million Jury Verdict in Patent Infringement Case

Sight Sciences, of Menlo Park, California, reported April 29 that ithad received a $34 million jury trial verdict in its patent infringement case against Ivantis and acquirer Alcon. The suit, filed...

4/24/2024
ASCRSCataractNewsletterSurgical
ASCRS Marks 50 Years with Look Back at Cataract Surgery in 1974
ASCRS Marks 50 Years with Look Back at Cataract Surgery in 1974

The ASCRS commemorated its 50th anniversary at its 2024 annual meeting by re-creating an ophthalmologist’s office and surgery suite from the 1970s in the exhibit hall. The display served as a remin...

4/24/2024
ASCRSCataractIOLNewsletterSurgical
J&J Vision Launches Tecnis Odyssey PC-IOL at 2024 ASCRS Meeting
J&J Vision Launches Tecnis Odyssey PC-IOL at 2024 ASCRS Meeting

Johnson & Johnson Vision launched and touted the Tecnis Odyssey presbyopia-correcting IOL at a number of venues at the 2024 ASCRS meeting. Blake Williamson, MD, and Priya Matthews, MD, described J&...

4/24/2024
ASCRSCataractIOLNewsletterSurgical
RxSight Launches the LAL+ IOL with Large ASCRS Program
RxSight Launches the LAL+ IOL with Large ASCRS Program

RxSight continued to build momentum for its post-op adjustable IOL with a big presence at the 2024 ASCRS meeting, including an Eyecelerator presentation on the new LAL+ and 14 speaker sessions at t...

4/24/2024
ASCRSCataractNewsletterSurgical
Rayner and Carl Zeiss Meditec Display Recently Acquired Phaco Machines
Rayner and Carl Zeiss Meditec Display Recently Acquired Phaco Machines

The US ultrasonic cataract machine market has been dominated by Alcon, Bausch + Lomb, and Johnson & Johnson for more than a decade, so it’s unusual to learn of a new phaco machine being launched by...

4/24/2024
NewsletterRefractiveSurgical
Slade’s Steinert Lecture Bolsters Value of Refractive Lens Exchange
Slade’s Steinert Lecture Bolsters Value of Refractive Lens Exchange

Stephen Slade, MD, promoted the value of refractive lens exchange (RLE) during the Steinert Lecture at the 2024 ASCRS meeting’s Refractive Subspecialty Day. RLE is an elective procedure that remove...

4/24/2024
ASCRSNewsletterRefractiveSurgical
ASCRS Meeting Showcases New Lenticule Extraction Platforms
ASCRS Meeting Showcases New Lenticule Extraction Platforms

Lenticule extraction (LE) continues to advance as new platforms come to the market. The 2024 ASCRS meeting showcased improved LE features that have enhanced the patient and surgeon experience. Doct...

4/24/2024
ASCRSCataractDry EyeNewsletterRefractiveSurgical
Dry Eye Screening Before Surgery Seems Logical, but Hurdles Remain
Dry Eye Screening Before Surgery Seems Logical, but Hurdles Remain

The need to continue lobbying for dry eye evaluation prior to patients undergoing anterior segment surgery is somewhat baffling. Such testing seems like an obvious approach for the many patients wh...

4/24/2024
NewsletterPharmaRegulationSurgical
Chambers Retires from US FDA After 36-Plus Years of Ophthalmic Drug Review
Chambers Retires from US FDA  After 36-Plus Years of Ophthalmic  Drug Review

Wiley Chambers, MD, an ophthalmologist who conducted or supervised the review of ophthalmic drugs at the US FDA for 36½ years, retired from the agency Jan. 13, 2024. The 65-year-old is now serving ...

4/24/2024
CataractIOLNewsletterRegulationSurgical
BVI Medical Launches Podeye Hydrophobic Monofocal IOL in Japan
BVI Medical Launches Podeye Hydrophobic Monofocal IOL in Japan

BVI Medical announced April 17 that it had launched its Podeye hydrophobic monofocal IOL in Japan, following approval by the Japanese Pharmaceuticals and Medical Devices Agency. The lens was set to...

4/24/2024
CataractIOLNewsletterPremiumSurgical
Weekly Surgeon Poll, April 2024
Weekly Surgeon Poll, April 2024

4/19/2024
BreakingCataractIOLSurgical
BVI Medical Launches Podeye Hydrophobic Monofocal IOL in Japan
BVI Medical Launches Podeye Hydrophobic Monofocal IOL in Japan

BVI Medical announced April 17 that it had launched its Podeye hydrophobic monofocal IOL in Japan, following approval by the Japanese Pharmaceuticals and Medical Devices Agency. The lens was set to...

4/19/2024
BreakingCataractIOLRevenueSurgical
J&J Vision Reports Q1-2024 Surgical Revenue of $348 Million
J&J Vision Reports Q1-2024 Surgical Revenue of $348 Million

J&J Vision’s Q1-2024 global surgical revenue totaled $348 million, up 0.3 percent (+1.1 percent cc) over $347 million in Q1-2023, parent Johnson & Johnson, of New Brunswick, New Jersey, reported Ap...

4/19/2024
BreakingCataractData SecurityIOLSurgical
Japanese IOL Maker Hoya Halts Production After Cyberattack
Japanese IOL Maker Hoya Halts Production After Cyberattack

Japanese intraocular lens maker Hoya reported on April 4 that production of several of its products had stopped after a computer system failure, “most likely caused by unauthorized access” to its s...

4/12/2024
BreakingEmergingEuropeFundingGlaucomaSurgical
LEP Raises Funding to Advance Glaucoma Implant Targeting Inflammation, Fibrosis
LEP Raises Funding to Advance Glaucoma Implant Targeting Inflammation, Fibrosis

Ireland-based LEP Biomedical reported April 4 that it had closed a pre-seed funding round of €100 thousand to advance its HyaGuard platform. HyaGuard is a biodegradable, subconjunctival insert desi...

4/12/2024
BreakingCataractIOLSurgical
Rayner Marks Sale of 5 Millionth RayOne IOL
Rayner Marks Sale of 5 Millionth RayOne IOL

UK-based Rayner reported April 3 that it had sold its 5 millionth RayOne lens and 11 millionth lens made from RayAcryl, Rayner’s proprietary hydrophilic acrylic material. Rayner, founded in 1910, r...

4/5/2024
BreakingDigitalIndustryMicroscopesSurgical
Beyeonics Vision Appoints A. Burton Tripathi, PhD, as CEO
Beyeonics Vision Appoints A. Burton Tripathi, PhD, as CEO

Israel’s Beyeonics Vision announced March 28 that it had appointed A. Burton Tripathi, PhD, as its new chief executive officer. Tripathi was formerly CEO of TrueVision 3D Surgical. After Alcon acqu...

3/29/2024
BreakingPharmaRegulationSurgical
Chambers Retires from US FDA After 36-Plus Years of Ophthalmic Drug Review
Chambers Retires from US FDA After 36-Plus Years of Ophthalmic Drug Review

Wiley Chambers, MD, an ophthalmologist who conducted or supervised the review of ophthalmic drugs at the US FDA for 36 1/2 years, retired from the agency Jan. 13, 2024. The 65-year-old is now servi...

3/29/2024
BreakingCornealDealsRetinaSurgical
ABVC BioPharma Sells Global Rights to Vitreous Substitute to ForSeeCon Eye for $30 Million Up Front
ABVC BioPharma Sells Global Rights to Vitreous Substitute to ForSeeCon Eye for $30 Million Up Front

ABVC BioPharma announced March 26 that it had agreed to license its ophthalmology pipeline, including the vitreous substitute candidate Vitargus, to ForSeeCon Eye. ABVC, of Fremont, California, say...

3/29/2024
BreakingCataractCornealIndustryRefractiveSurgical
Alcon Appoints Terry Kim, MD, as CMO, Head of Global Medical Safety
Alcon Appoints Terry Kim, MD, as CMO, Head of Global Medical Safety

Alcon announced March 26 that Terry Kim, MD, would join the company in April as chief medical officer (CMO) and head of global medical safety. Kim, who specializes in cornea, cataract, and refracti...

3/29/2024
BreakingCataractEnvironmentIOLSurgical
Rayner Updates Packaging to Lessen Impact on Environment
Rayner Updates Packaging to Lessen Impact on Environment

UK-based Rayner announced March 25 that it would update its packaging to reduce the company’s carbon footprint and improve ease of use for customers. Rayner said the new packaging will replace pape...

3/22/2024
BreakingDealsDry EyePharmaRevenueSurgical
2023 Ophthalmic Revenue Roundup for Harrow, Alimera Sciences, and EyePoint
2023 Ophthalmic Revenue Roundup for Harrow, Alimera Sciences, and EyePoint

Nashville, Tennessee-based Harrow reported March 19 that its 2023 revenue was $130.2 million, a 47 percent increase over $88.6 million in 2022. The company generated record quarterly revenue in Q4-...

3/22/2024
BreakingFundingSurgical
Bascom Palmer Uses $1 Million Gift to Launch Whole Eye Transplant Initiative
Bascom Palmer Uses $1 Million Gift to Launch Whole Eye Transplant Initiative

Bascom Palmer Eye Institute reported March 5 that it would use a $1 million donation to fast-forward its initiative to transplant a whole eye. The hospital, part of the University of Miami, said th...

3/22/2024
BreakingCataractIOLIndiaSurgical
Alcon Launches Clareon PC-IOLs in India
Alcon Launches Clareon PC-IOLs in India

Alcon announced March 12 that it had launched presbyopia-correcting intraocular lenses (IOLs) in India made of the Clareon glistening-free material. The Clareon platform is available in India in tw...

3/21/2024
CataractIOLNewsletterPremiumSurgical
Robust Premium IOL Revenue Growth Expected to Continue Through 2029
Robust Premium IOL Revenue Growth Expected to Continue Through 2029

The global intraocular lens market has shown strong growth during the past seven years, increasing from $3.8 billion in 2017 to $5.8 billion in 2023, for a compound annual growth rate of nearly 8 p...

3/21/2024
CornealGlaucomaNewsletterSurgical
CorNeat Vision Launches EverPatch Ophthalmic Graft Material in the US
CorNeat Vision Launches EverPatch Ophthalmic Graft Material in the US

Israel-based CorNeat Vision announced Feb. 27 that it had launched its EverPatch scleral reinforcement patch in the US. The device was cleared by the US FDA in June 2023. The graft is the first syn...

3/21/2024
NewsletterRefractiveRegulationSurgical
FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads
FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads

The Federal Trade Commission has sent notices to about 160 thousand individuals who received LASIK consultations at LasikPlus or Joffe MediCenter that they may be eligible for a settlement payout. ...

3/21/2024
CataractDiagnosticGlaucomaNewsletterRefractiveRegulationRetinaSurgical
Select US FDA Approvals and Clearances in February 2024
Select US FDA Approvals and Clearances in February 2024

The US FDA granted two clearances through the ophthalmic device division using the 510(k) pathway in February 2024, according to the agency’s database. CATS Tonometer received clearance for its ton...

3/21/2024
GlaucomaNewsletterPharmaSurgical
Celanese Announces Launch of Glaukos’ iDose TR Travoprost Implant
Celanese Announces Launch of Glaukos’ iDose TR Travoprost Implant

Celanese announced the commercial launch Feb. 29 of Glaukos’ iDose TR intracameral travoprost implant for glaucoma. Celanese, a specialty materials and chemical company based in Dallas, Texas, prod...

3/21/2024
CataractIOLIndiaNewsletterSurgical
Alcon’s Vivity EDOF IOL Reaches Milestone of 1 Million Implantations
Alcon’s Vivity EDOF IOL Reaches Milestone of 1 Million Implantations

Alcon reported March 6 that the AcrySof IQ Vivity and Clareon Vivity extended depth of focus (EDOF) intraocular lenses (IOLs) had surpassed more than 1 million implantations worldwide. According to...

3/21/2024
CataractMeetingNewsletterSurgical
Meet with Market Scope at the 2024 ASCRS Meeting
Meet with Market Scope at the 2024 ASCRS Meeting

Market Scope will be located at Booth 3080 at the 2024 ASCRS meeting in Boston, set for April 5-8. Contact us to set up a time to discuss your custom research needs and to learn about our new repor...

3/15/2024
BreakingCataractDry EyeGlaucomaRevenueSurgical
2023 Ophthalmic Revenue Roundup for Sight Sciences and Ocular Therapeutix
2023 Ophthalmic Revenue Roundup for Sight Sciences and Ocular Therapeutix

Sight Sciences reported March 7 that it generated 2023 total revenue of $81.1 million, an increase of 14 percent over $71.3 million in 2022. Surgical glaucoma revenue in 2023 was $74.3 million, a 1...

3/15/2024
BreakingCataractIOLSurgical
Alcon’s Vivity EDOF IOL Reaches Milestone of 1 Million Implantations
Alcon’s Vivity EDOF IOL Reaches Milestone of 1 Million Implantations

Alcon reported March 6 that the AcrySof IQ Vivity and Clareon Vivity extended depth of focus (EDOF) intraocular lenses (IOLs) had surpassed more than 1 million implantations worldwide. According to...

3/8/2024
BreakingRefractiveRegulationSurgical
FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads
FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads

The Federal Trade Commission has sent notices to about 160 thousand individuals who received LASIK consultations at LasikPlus or Joffe MediCenter that they may be eligible for a settlement payout. ...

3/8/2024
BreakingGlaucomaPharmaSurgical
Celanese Announces Commercial Launch of Glaukos’ iDose TR Travoprost Implant
Celanese Announces Commercial Launch of Glaukos’ iDose TR Travoprost Implant

Celanese announced the commercial launch Feb. 29 of Glaukos’ iDose TR intracameral travoprost implant for glaucoma. Celanese, a global specialty materials and chemical company based in Dallas, Texa...

3/1/2024
BreakingCornealDry EyeGlaucomaIOLRefractiveRetinaRevenueSurgical
2023 Ophthalmic Revenue Roundup for Alcon, Bausch + Lomb, STAAR, Glaukos, Apellis, and Tarsus
2023 Ophthalmic Revenue Roundup for Alcon, Bausch + Lomb, STAAR, Glaukos, Apellis, and Tarsus

Alcon reported Feb. 27 that its full year 2023 net sales totaled $9.4 billion, an 8 percent increase (+10 percent cc) over $8.7 billion in 2022. Q4-2023 sales were $2.3 billion, an 8 percent increa...

3/1/2024
BreakingCornealGlaucomaSurgical
CorNeat Vision Launches EverPatch Ophthalmic Graft Material in the US
CorNeat Vision Launches EverPatch Ophthalmic Graft Material in the US

Israel-based CorNeat Vision announced Feb. 27 that it had launched itsEverPatch scleral reinforcement patch in the US. The device was cleared by the US FDA in June 2023. The graft is the first synt...

2/23/2024
BreakingCataractEuropeIOLMeetingSurgical
VSY Launches Enova Maestro Trifocal Toric Preloaded IOL at ESCRS Winter Meeting
VSY Launches Enova Maestro Trifocal Toric Preloaded IOL at ESCRS Winter Meeting

Germany’s VSY Biotechnology launched its Enova Maestro trifocal toric preloaded intraocular lens (IOL) at the European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meeting, held Feb. ...

2/23/2024
BreakingEuropeGlaucomaMeetingSurgical
Sight Sciences Reports Launching of Omni Ergo-Series for Canaloplasty in Europe at ESCRS Winter Meeting
Sight Sciences Reports Launching of Omni Ergo-Series for Canaloplasty in Europe at ESCRS Winter Meeting

Sight Sciences announced Feb. 14 that it would launch the Ergo-Series of its Omni system for canaloplasty in Europe at the European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meetin...

2/22/2024
AcquisitionsDeviceNewsletterRetinaSurgical
Retinal Device Market Awaits Technological Impact of Zeiss’ DORC Acquisition
Retinal Device Market Awaits Technological Impact of Zeiss’ DORC Acquisition

Carl Zeiss Meditec’s acquisition of DORC (Dutch Ophthalmic Research Center) will change the players in the retinal surgical equipment market, but whether it will lead to any major changes in market...

2/22/2024
DealsFundingGene TherapyGlaucomaNewsletterRetinaSurgical
4DMT Leads Latest Ophthalmic Fundraising with $300 Million Public Offering
4DMT Leads Latest Ophthalmic Fundraising with $300 Million Public Offering

4D Molecular Therapeutics led recent ophthalmic fundraising efforts with a $300 million upsized public offering to continue advancing its retinal gene therapy candidate. Financing announced in the ...

2/22/2024
GlaucomaMeetingNewsletterSurgical
Top Innovators Delve into Latest Concepts at G360’s New Horizons Forum
Top Innovators Delve into Latest Concepts at G360’s New Horizons Forum

Two of ophthalmology’s leading innovators headlined the New Horizons Forum at the Glaucoma 360 meeting. Sean Ianchulev, MD—arguably the most prolific ophthalmic product inventor in the US—led off t...

2/22/2024
CataractNewsletterRegulationSurgical
MAC Drops Plan to Require Visual Acuity of 20/50 or Worse for Cataract Surgery
MAC Drops Plan to Require Visual Acuity of 20/50 or Worse for Cataract Surgery

Wisconsin Physician Services (WPS), a Medicare Administrative Contractor (MAC) in the US, has abandoned a proposal to require visual acuity of 20/50 or worse for cataract surgery to be medically ne...

2/22/2024
CataractEuropeIOLNewsletterSurgical
Johnson & Johnson MedTech Launches Tecnis PureSee PC-IOL in EMEA Countries
Johnson & Johnson MedTech Launches Tecnis PureSee PC-IOL in EMEA Countries

Johnson & Johnson MedTech announced Feb. 15 that its Tecnis PureSee refractive presbyopia-correcting intraocular lens (IOL) is now available in select markets in Europe, the Middle East, and Africa...

2/22/2024
CataractEuropeIOLNewsletterSurgical
February 2024 Weekly Surgeon Poll: US vs. Western European Ophthalmologists
February 2024 Weekly Surgeon Poll: US vs. Western European Ophthalmologists

2/22/2024
CataractClinical TrialCornealDealsDiagnosticDry EyeGene TherapyGlaucomaIOLIndustryNewsletterPresbyopiaRegulationRetinaSurgical
February 2024 Ophthalmic News Briefs
February 2024 Ophthalmic News Briefs

Amneal Pharmaceuticals announced Jan. 10 that it had received US FDA approval for and launched generic fluorometholone eye drops. The product is indicated for the treatment of corticosteroid-respon...

2/16/2024
BreakingCataractEuropeIOLSurgical
Johnson & Johnson MedTech Launches Tecnis PureSee PC-IOL in Select EMEA Countries
Johnson & Johnson MedTech Launches Tecnis PureSee PC-IOL in Select EMEA Countries

Johnson & Johnson MedTech announced Feb. 15 that its Tecnis PureSee refractive presbyopia-correcting intraocular lens (IOL) is now available in select markets in Europe, the Middle East, and Africa...

2/16/2024
BreakingChinaIOLRefractiveRevenueSurgical
Ophthalmic Quarterly Revenue Roundup for Carl Zeiss Meditec and Hoya
Ophthalmic Quarterly Revenue Roundup for Carl Zeiss Meditec and Hoya

Carl Zeiss Meditec reported Feb. 9 that ophthalmology revenue for the last three months of 2023, its first quarter of fiscal year 2023/2024, totaled €351.1 million ($378.5 million, converted Feb. 9...

2/16/2024
AllergyBreakingDealsDry EyePharmaSurgical
Harrow Licenses Rights to Five Drugs to Apotex for Canada
Harrow Licenses Rights to Five Drugs to Apotex for Canada

Harrow reported Feb. 15 that it had licensed to Apotex exclusive marketing and distribution rights to Verkasia and over-the-counter Cationorm Plus in the Canadian market. In addition, Apotex will p...

2/16/2024
BreakingIndustryLaserRefractiveSurgical
Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer
Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer

Ace Vision Group announced Feb. 13 that it had named Val Kolesnitchenko, MD, as chief scientific officer. Most recently, Kolesnitchenko held the position of executive director of global scientific ...

2/9/2024
BreakingCataractDealsSurgical
Omeros Changes Up Royalty Agreement with DRI Healthcare for Additional $115 Million
Omeros Changes Up Royalty Agreement with DRI Healthcare for Additional $115 Million

Seattle-based Omeros reported Feb. 1 that it had changed up its agreement with DRI Healthcare Trust for Omidria royalties. DRI, based in Toronto, Canada, has paid Omeros an additional $115 million ...

2/9/2024
BreakingCataractEuropeSurgical
Keranova Appoints Denise Hoblingre as CEO
Keranova Appoints Denise Hoblingre as CEO

France’s Keranova recently announced that Denise Hoblingre had been appointed chief executive officer. She succeeds company co-founder Fabrice Romano, DVM. Hoblingre joined Keranova at its inceptio...

2/2/2024
BreakingCataractRegulationSurgical
MAC Drops Plan to Require Visual Acuity of 20/50 or Worse for Cataract Surgery
MAC Drops Plan to Require Visual Acuity of 20/50 or Worse for Cataract Surgery

Wisconsin Physician Services (WPS), a Medicare Administrative Contractor (MAC) in the US, has abandoned a proposal to require visual acuity of 20/50 or worse for cataract surgery to be medically ne...

1/26/2024
BreakingGlaucomaIOLPharmaRevenueSurgical
2023 Ophthalmic Revenue Roundup for J&J Vision and Nicox
2023 Ophthalmic Revenue Roundup for J&J Vision and Nicox

Johnson & Johnson reported Jan. 23 that its full year 2023 global surgical vision revenue was $1.37 billion, a 4.9 percent increase (+5.8 percent cc) over $1.31 billion in 2022. Revenue was down 1....

1/23/2024
GlaucomaNewsletterRegulationSurgical
US FDA Approves iDose TR (Travoprost Implant) from Glaukos for Glaucoma
US FDA Approves iDose TR (Travoprost Implant) from Glaukos for Glaucoma

Glaukos reported Dec. 14 that the US FDA had approved its new drug application for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg, indicated for the reduction ...

1/23/2024
GlaucomaNewsletterRegulationSurgical
2023 in Review: MAC Turmoil Shifts Landscape for Canal-Based Glaucoma Devices
2023 in Review: MAC Turmoil Shifts Landscape for Canal-Based Glaucoma Devices

Medicare administrative contractors (MACs) threw the near-term future of the glaucoma device market into turmoil in early 2023 when they challenged the medical necessity of canal-based surgical pro...

1/23/2024
DealsNewsletterRetinaSurgical
2023 in Review: Zeiss Fills Retina Gap with $1.1 Billion Acquisition of DORC
2023 in Review: Zeiss Fills Retina Gap with $1.1 Billion Acquisition of DORC

Carl Zeiss Meditec announced in December that Zeiss had agreed to acquire Netherlands-based Dutch Ophthalmic Research Center (DORC) from investment firm Eurazeo for €985 million ($1.1 billion). Eua...

1/23/2024
NewsletterRegulationSurgical
Federal Health Accelerator to Focus on Transplanting Whole Donor Eyes
Federal Health Accelerator to Focus on Transplanting Whole Donor Eyes

A new accelerator within the Health and Human Services Department announced Jan. 11 the creation of a program designed to transplant whole donor eyes. Such a treatment would address the millions of...

1/19/2024
BreakingCataractDealsSurgical
Rayner Acquires Switzerland-Based This AG, Maker of Sophi Phaco Machines
Rayner Acquires Switzerland-Based This AG, Maker of Sophi Phaco Machines

UK-based Rayner announced Jan. 17 that it had acquired Switzerland’s This AG, the maker of Sophi phacoemulsification machines. No financial details were disclosed. Sophi phaco machines are battery-...

1/12/2024
BreakingGlaucomaRegulationSurgical
US MACs Retire Coverage Policies That Would Have Limited Some MIGS Procedures
US MACs Retire Coverage Policies That Would Have Limited Some MIGS Procedures

Five Medicare administrative contractors (MACs) have withdrawn and retired final policies that would have stopped Medicare coverage of common minimally invasive glaucoma surgeries in their US juris...

1/12/2024
BreakingRefractiveRegulationSurgical
US FDA Approves Teneo Excimer Laser Platform from Bausch + Lomb for LASIK Vision Correction
US FDA Approves Teneo Excimer Laser Platform from Bausch + Lomb for LASIK Vision Correction

Bausch + Lomb announced Jan. 8 that the US FDA had approved the Teneo excimer laser platform for laser-assisted in situ keratomileusis (LASIK) vision correction surgery for myopia and myopic astigm...

1/12/2024
BreakingRegulationSurgical
Federal Health Accelerator to Focus on Transplanting Whole Donor Eyes
Federal Health Accelerator to Focus on Transplanting Whole Donor Eyes

A new accelerator within the Health and Human Services Department announced Jan. 11 the creation of a program designed to transplant whole donor eyes. Such a treatment would address the millions of...

1/12/2024
BreakingRefractiveRegulationSurgical
Carl Zeiss Meditec’s Updated VisuMax 800 and SMILE Software Gain US FDA Approval
Carl Zeiss Meditec’s Updated VisuMax 800 and SMILE Software Gain US FDA Approval

Carl Zeiss Meditec reported Jan. 11 that the US FDA had approved its updated VisuMax 800 femtosecond refractive laser and related SMILE software for surgically treating nearsightedness with or with...

1/5/2024
BreakingCataractIndustrySurgical
Centricity’s Leonard Borrmann, PharmD, to Succeed Rob Thornhill as CEO
Centricity’s Leonard Borrmann, PharmD, to Succeed Rob Thornhill as CEO

Centricity Vision, of Carlsbad, California, announced Dec. 20 that Leonard Borrmann, PharmD, formerly the company’s head of research and development, had been named chief executive officer. Borrman...

12/29/2023
BreakingCataractSurgical
HelpMeSee Wins Award for its Cataract Surgery Training Simulator
HelpMeSee Wins Award for its Cataract Surgery Training Simulator

HelpMeSee, a global nonprofit group that provides simulation training in low-cost cataract surgery, announced that it had received the 2023 Modeling and Simulation Award from the National Training ...

12/20/2023
BreakingCataractEuropeIOLSurgical
Ophtec Launches Precizon Go Enhanced Monofocal IOL
Ophtec Launches Precizon Go Enhanced Monofocal IOL

Dutch company Ophtec announced Dec. 11 the launch of its Precizon Go intraocular lens (IOL), a “monofocal plus” lens designed to provide distance and enhanced intermediate vision. Precizon Go featu...

12/15/2023
BreakingCataractDealsRetinaSurgical
Carl Zeiss Meditec Acquires DORC for $1.1 Billion
Carl Zeiss Meditec Acquires DORC for $1.1 Billion

Carl Zeiss Meditec announced Dec. 15 that it had agreed to acquire Netherlands-based Dutch Ophthalmic Research Center (DORC) from investment firm Eurazeo, of Paris. DORC, founded in 1983, is a lead...

12/15/2023
BreakingGlaucomaRegulationSurgical
US FDA Approves iDose TR (Travoprost Implant) from Glaukos for Glaucoma
US FDA Approves iDose TR (Travoprost Implant) from Glaukos for Glaucoma

Glaukos reported Dec. 14 that the US FDA had approved its new drug application for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg, indicated for the reduction ...

12/15/2023
BreakingDiagnosticIOLRevenueSurgical
Carl Zeiss Meditec Reports Annual Ophthalmic Revenue of $1.67 Billion
Carl Zeiss Meditec Reports Annual Ophthalmic Revenue of $1.67 Billion

Carl Zeiss Meditec reported Dec. 12 that ophthalmology revenue for is full fiscal year 2022/2023, which ended Sept. 30, was €1.58 billion ($1.67 billion, converted Sept. 30), a 7.3 percent increase...

12/15/2023
BreakingIndustryInstrumentsSurgical
Corza Opens New Development Facility in Fenton, Missouri
Corza Opens New Development Facility in Fenton, Missouri

Corza Medical reported Nov. 30 that it had opened a new Ophthalmology Center of Technology and Innovation in Fenton, Missouri, which is part of the St. Louis region. The facility, which covers 30 t...

12/14/2023
InstrumentsNewsletterSurgical
Ophthalmic Reusable Instruments Gaining Clout Amid Global Sustainability Initiatives
Ophthalmic Reusable Instruments Gaining Clout Amid Global Sustainability Initiatives

Sustainability initiatives in the ophthalmic market are changing the perception of reusable and disposable instruments. Reusable instruments are gaining ground, as more popular single-use instrumen...

12/14/2023
IndustryInstrumentsNewsletterSurgical
Corza Opens New Development Facility in Fenton, Missouri
Corza Opens New Development Facility in Fenton, Missouri

Corza Medical reported Nov. 30 that it had opened a new Ophthalmology Center of Technology and Innovation in Fenton, Missouri, which is part of the St. Louis region. The facility, which covers 30 t...

12/14/2023
CataractNewsletterSurgical
Patients Blinded After Fungal Infections Mar Free Eye Surgery Event in Brazil
Patients Blinded After  Fungal Infections Mar Free Eye Surgery Event in Brazil

A free ophthalmic surgery event in northern Brazil in September was tarnished when 104 of 141 pa-tients—nearly 74 percent—suffered serious postoperative complications from fungal endophthalmitis. T...

12/14/2023
CataractIOLNewsletterRefractiveSurgical
Weekly Surgeon Poll, December 2023
Weekly Surgeon Poll, December 2023

12/8/2023
BreakingCataractRegulationSurgical
MAC WPS Proposes Limiting Cataract Surgery to Those with 20/50 or Worse Vision
MAC WPS Proposes Limiting Cataract Surgery to Those with 20/50 or Worse Vision

Wisconsin Physician Services (WPS), a Medicare Administrative Contractor (MAC) in the US, has proposed requiring visual acuity of 20/50 or worse for cataract surgery to be medically necessary and p...

12/8/2023
BreakingCataractClinical TrialRegulationSurgical
US FDA Gives Green Light to Phase II Trial of VivaVision’s Candidate for Post-Cataract Inflammation
US FDA Gives Green Light to Phase II Trial of VivaVision’s Candidate for Post-Cataract Inflammation

VivaVision, of Wenzhou, China, announced Dec. 4 that the US FDA had cleared a Phase II trial of its VVN461 eye drop candidate for postoperative inflammation after cataract surgery. VVN461 is a pote...

12/8/2023
BreakingGlaucomaSurgical
France’s Ciliatech Unveils New Design of CID Glaucoma Surgical Device
France’s Ciliatech Unveils New Design of CID Glaucoma Surgical Device

France’s Ciliatech revealed on Dec. 5 a new design of its CID (Cilioscleral Interpositioning Device), following the filing of additional patents. Ciliatech says its approach with the CID avoids the...

12/8/2023
BreakingCataractSurgical
Patients Blinded After Fungal Infections Mar Free Eye Surgery Event in Brazil
Patients Blinded After Fungal Infections Mar Free Eye Surgery Event in Brazil

A free ophthalmic surgery event in northern Brazil in September was tarnished when 104 of 141 patients—nearly 74 percent—suffered serious postoperative complications from fungal endophthalmitis. Th...

11/22/2023
BreakingLaserRevenueSurgical
Q3-2023 Ophthalmic Revenue Roundup for Alcon, Iridex, and Lensar
Q3-2023 Ophthalmic Revenue Roundup for Alcon, Iridex, and Lensar

Alcon reported Nov. 14 that its Q3-2023 net sales totaled $2.3 billion, an 8 percent increase (+9 percent cc) over $2.1 billion in Q3-2022. Surgical net sales for implantables, consumables, and equ...

11/21/2023
AAOCataractMeetingNewsletterSurgical
Pros and Cons of Same-Day Cataract Surgery Debated During AAO Refractive Day
Pros and Cons  of Same-Day Cataract Surgery Debated During AAO Refractive Day

The advantages and disadvantages of immediate sequential bilateral cataract surgery (ISBCS) took center stage during a 2023 AAO Refractive Day session that tasked Rupert Menapace, MD (Austria), wit...

11/21/2023
AAOMeetingMyopiaNewsletterRefractiveSurgical
US Refractive Surgeons Grapple with Treatment Options for High Myopes
US Refractive Surgeons Grapple with Treatment Options for High Myopes

Surgeons attending the Refractive Subspecialty Day at the 2023 AAO meeting in San Francisco debated the ideal treatment options for patients with moderate to high myopia. Practices shared widely di...

11/21/2023
NewsletterRefractiveSurgical
STAAR Surgical Celebrates ICL Procedure’s 30th Anniversary
STAAR Surgical Celebrates ICL Procedure’s  30th Anniversary

STAAR Surgical reported Oct. 17 that October 2023 marked the 30th anniversary of the first implantations of the company’s Implantable Collamer Lens (ICL). The lens is intended to be implanted betwe...

11/21/2023
CataractFLACSNewsletterRegulationSurgical
Oertli Files for US FDA 510(k) Clearance for Phaco Portion of Lensar Ally System
Oertli Files for US FDA 510(k) Clearance for Phaco Portion of Lensar Ally System

Lensar and Swiss company Oertli announced Oct. 30 that Oertli had filed for US FDA 510(k) clearance for its Faros easyPhaco phacoemulsification system. If cleared, the Faros will be integrated into...

11/21/2023
CataractIOLNewsletterPremiumSurgical
US Dominance of Premium Cataract Surgery Market Expected to Grow
US Dominance of Premium Cataract Surgery Market Expected to Grow

New technology and competition are expected to further expand the dominance of the US premium cataract surgery (PCS) market over the next five years. The US is already the dominant PCS market globa...

11/21/2023
Clinical TrialCornealGlaucomaNewsletterRegulationRetinaSurgical
Clinical Trial Updates for Ophthalmic Candidates, November 2023
Clinical Trial Updates for Ophthalmic Candidates, November 2023

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

11/21/2023
AAODiagnosticDigitalDry EyeGlaucomaMeetingNewsletterRefractiveRegulationRetinaSurgical
Buzzworthy Topics at the 2023 AAO Meeting
Buzzworthy Topics at the 2023 AAO Meeting

Dry Eye: New products kept generating buzz around dry eye. Bausch + Lomb leaned into the promotion of Miebo, the new, first-in-class drug therapy that directly targets tear evaporation. Diagnostic ...

11/21/2023
AAOCataractIOLMeetingNewsletterSurgical
RxSight Announces Controlled Launch of LAL+ with Extended EDOF Functionality
RxSight Announces Controlled Launch  of LAL+ with Extended EDOF Functionality

RxSight—already the fastest growing IOL company in the US—is conducting a controlled launch of an additional version of the Light Adjustable Lens (LAL), referred to as the LAL+. Stephen Slade, MD, ...

11/21/2023
AAOCataractIOLMeetingNewsletterSurgical
Surgeons Compare Trifocal and EDOF IOLs During AAO Refractive Day
Surgeons Compare Trifocal and EDOF IOLs During AAO Refractive Day

Trifocal IOLs went head-to-head with extended depth of focus lenses during the 2023 AAO Refractive Day program as Damien Gatinel, MD, PhD (France), advocated for trifocal models and Douglas Koch, M...

11/21/2023
AAOEnvironmentMeetingNewsletterSurgical
US Ophthalmologists Emphasize Action as Industry Inches Toward Greener Practices
US Ophthalmologists Emphasize Action as Industry Inches Toward Greener Practices

Sustainability sessions at the 2023 AAO meeting echoed the sentiment of the ESCRS and other ophthalmic meetings throughout the year. US ophthalmologists discussed how practices can implement protoc...

11/21/2023
AAOCataractDiagnosticDigitalGlaucomaMeetingNewsletterSurgical
Diagnostic Leaders Showcase Devices, Collaborations at AAO Meeting
Diagnostic Leaders Showcase Devices, Collaborations at AAO Meeting

Notable diagnostic innovations showcased at the 2023 meeting of the American Academy of Ophthalmology were Topcon’s Tempo perimeter and Heidelberg Engineering’s Anterion anterior OCT platform. Also...

11/21/2023
GlaucomaNewsletterRegulationSurgical
Five MACs Finalize Plans to Curb Coverage of Non-stent Glaucoma Procedures
Five MACs Finalize Plans to Curb Coverage of Non-stent  Glaucoma Procedures

Five of the seven Medicare administrative contractors (MACs) in the US have issued their final reimbursement plans for minimally invasive glaucoma surgery (MIGS) procedures, confirming that they wo...

11/21/2023
CataractIOLNewsletterSurgical
Bausch + Lomb Launches enVista Aspire Intermediate-Optimized Monofocal and Toric IOLs in US
Bausch + Lomb Launches enVista Aspire Intermediate-Optimized Monofocal and Toric IOLs in US

Bausch + Lomb announced Oct. 18 the US launch of its enVista Aspire monofocal and toric intraocular lenses with intermediate-optimized optics. The company said that, unlike conventional spherical m...

11/21/2023
CornealDiagnosticEmergingGene TherapyGlaucomaNewsletterRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, November 2023
Emerging Companies Pursuing Ophthalmic Indications, November 2023

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

11/21/2023
ChinaDealsDiagnosticDry EyeGene TherapyGenericsGlaucomaIndustryNewsletterPresbyopiaRegulationRetinaSurgical
November 2023 Ophthalmic News Briefs
November 2023 Ophthalmic News Briefs

Specialty pharma company Padagis announced Oct. 13 the launch of its brinzolamide ophthalmic suspension, a generic version of Novartis’ Azopt for glaucoma. Padagis, with offices in the US and Israe...

11/3/2023
BreakingDry EyeGlaucomaPharmaRefractiveRetinaRevenueSurgical
Q3-2023 Ophthalmic Revenue Roundup for Regeneron, Bausch + Lomb, AbbVie, and Five Others
Q3-2023 Ophthalmic Revenue Roundup for Regeneron, Bausch +  Lomb, AbbVie, and Five Others

Regeneron of Tarrytown, New York, reported Nov. 2 that its Q3-2023 US revenue for Eylea (aflibercept) 2 mg and Eylea HD (a higher dose of aflibercept at 8 mg) was $1.49 billion, with Eylea HD accou...

11/3/2023
BreakingCataractRegulationSurgical
Oertli Files for US FDA 510(k) Clearance for Phaco Portion of Lensar Ally System
Oertli Files for US FDA 510(k) Clearance for Phaco Portion of Lensar Ally System

Lensar and Swiss company Oertli announced Oct. 30 that Oertli had filed for US FDA 510(k) clearance for its Faros easyPhaco phacoemulsification system. If cleared, the Faros will be integrated into...

11/3/2023
BreakingCataractDiagnosticSurgical
Bausch + Lomb Launches SeeNa Optical Biometry and Topography System in the US
Bausch + Lomb Launches SeeNa Optical Biometry and Topography System in the US

Bausch + Lomb announced on Oct. 30 the US launch of its SeeNa ophthalmic diagnostic system for refractive cataract patients, designed for integration with the company’s Eyetelligence surgical plann...

10/27/2023
BreakingCataractIOLSurgical
Bausch + Lomb Launches enVista Aspire Intermediate-Optimized Monofocal and Toric IOLs in US
Bausch + Lomb Launches enVista Aspire Intermediate-Optimized Monofocal and Toric IOLs in US

Bausch + Lomb announced Oct. 18 the US launch of its enVista Aspire monofocal and toric intraocular lenses with intermediate-optimized optics. The company said that, unlike conventional spherical m...

10/27/2023
BiologicsBreakingDry EyeGlaucomaPharmaRetinaRevenueSurgical
Q3-2023 Ophthalmic Revenue Roundup for Roche, Novartis, J&J Vision, and Nicox
Q3-2023 Ophthalmic Revenue Roundup for Roche, Novartis, J&J Vision, and Nicox

Swiss company Roche reported Oct. 19 that Q3-2023 Vabysmo sales were CHF 656 million ($732 million, converted Oct. 19), a 309 percent increase over CHF 173 million in Q3-2022. Vabysmo was approved ...

10/24/2023
CataractDry EyeESCRSGlaucomaIOLMeetingNewsletterRegulationSurgical
Buzzworthy Topics at the 2023 ESCRS Congress
Buzzworthy Topics at the 2023 ESCRS Congress

Minimally Invasive Glaucoma Surgery (MIGS): The ESCRS highlighted the growing importance of MIGS this year by holding the meeting’s first MIGS master class. Several speakers in other sessions extol...

10/24/2023
ESCRSMeetingNewsletterRefractiveSurgical
Lenticule Extraction Procedures Poised for Boost as Fourth Platform Enters Market at ESCRS
Lenticule Extraction Procedures Poised for Boost as Fourth Platform Enters Market at ESCRS

Johnson & Johnson Vision announced the launch of the Elita platform’s lenticule extraction (LE) procedure during the 2023 congress of the European Society of Cataract and Refractive Surgeons. The s...

10/24/2023
CornealESCRSMeetingNewsletterSurgical
Ukrainian Ophthalmologists Endure Complex Surgical Cases Amid War
Ukrainian Ophthalmologists Endure Complex Surgical Cases Amid War

Ukrainian ophthalmologists are struggling to restore sight to soldiers and confronting complex surgical cases, even as the Russian offensive continues in their country. A large contingent of 825 Uk...

10/24/2023
Clinical TrialDry EyeGene TherapyNewsletterRetinaSurgical
Clinical Trial Updates for Ophthalmic Candidates, October 2023
Clinical Trial Updates for Ophthalmic Candidates, October 2023

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

10/24/2023
CataractDiagnosticNewsletterSurgical
Weekly Surgeon Poll, October 2023
Weekly Surgeon Poll, October 2023

10/20/2023
BreakingIndustryRefractiveSurgical
STAAR Surgical Celebrates ICL Procedure’s 30th Anniversary
STAAR Surgical Celebrates ICL Procedure’s 30th Anniversary

STAAR Surgical reported Oct. 17 that October 2023 marked the 30th anniversary of the first implantations of the company’s Implantable Collamer Lens (ICL). The lens is intended to be implanted betwe...

10/20/2023
BreakingCataractDiagnosticSurgical
US FDA Clears Anterion Anterior Segment Diagnostic Platform from Heidelberg
US FDA Clears Anterion Anterior Segment Diagnostic Platform from Heidelberg

Heidelberg Engineering announced Oct. 13 that the US FDA had cleared its Anterion diagnostic platform for the anterior segment. The system gained CE marking in 2018. The Anterion combines biometry,...

10/13/2023
BreakingCataractIOLIndustrySurgical
HumanOptics Appoints Alexander Berka as New CEO
HumanOptics Appoints Alexander Berka as New CEO

HumanOptics, of Erlangen, Germany, announced Oct. 4 that it had named Alexander Berka as its chief executive officer. HumanOptics markets an artificial iris and the Triva, Torica, and Aspria intrao...

10/13/2023
BreakingCataractIndustrySurgical
HelpMeSee Appoints Bonnie An Henderson, MD, as President and CEO
HelpMeSee Appoints Bonnie An Henderson, MD, as President and CEO

HelpMeSee, a global nonprofit group that provides simulation training in low-cost cataract surgery, announced Oct. 10 that it had named Bonnie An Henderson, MD, as president and chief executive off...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more